REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 42 filers reported holding REATA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,781,000 | +192.6% | 18,500 | +35.0% | 0.44% | +392.2% |
| Q2 2019 | $1,292,000 | +10.4% | 13,700 | 0.0% | 0.09% | +66.7% |
| Q1 2019 | $1,170,000 | +117.5% | 13,700 | +42.7% | 0.05% | +45.9% |
| Q4 2018 | $538,000 | -20.5% | 9,600 | -72.0% | 0.04% | -41.3% |
| Q2 2016 | $677,000 | – | 34,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |